QS Investors’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
QS Investors's AMPH Position: Q2 2021 in Review
QS Investors held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2021 at 15,900 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #919.
QS Investors first reported a position in AMPH in Q2 2016 and has held it in 21 quarters since. The position peaked at $1.55M in Q2 2020. 146 funds tracked by Wall St. Rank hold AMPH as of Q2 2021.
- QS Investors held 15,900 shares of Amphastar Pharmaceuticals worth $321K as of Q2 2021.
- QS Investors left its Amphastar Pharmaceuticals share count unchanged in Q2 2021.
- Amphastar Pharmaceuticals made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #919 holding.
- QS Investors first reported a position in Amphastar Pharmaceuticals in Q2 2016 and has held it in 21 quarters since.
- QS Investors's Amphastar Pharmaceuticals position peaked at $1.55M in Q2 2020.
- 146 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2021.
Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.